Bank Julius Baer & Co. Ltd, Zurich Paratek Pharmaceuticals, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$4.7 - $7.24 $4,822 - $7,428	-1,026 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$6.81 - $10.93 $177 - $284	26 Added 2.6%	1,026 $7,000
Q1 2021 May 10, 2021	BUY	$6.14 - $8.31 $6,140 - $8,310	1,000 New	1,000 $7,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.